Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.185
-0.035 (-1.58%)
Aug 4, 2025, 11:56 AM - Market open

Company Description

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America.

It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as well as molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).

This segment also offers messenger RNA, oligonucleotides, CleanCap capping technology-based oligonucleotide building blocks, and custom enzyme development and manufacturing; and research products for labeling and detecting proteins in cells and tissue samples.

The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.

This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services.

The company’s products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, and antibody-based products to detect impurities during the production of biopharmaceutical products.

It serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies.

Maravai LifeSciences Holdings, Inc. was founded in 2014 and is headquartered in San Diego, California.

Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings logo
CountryUnited States
Founded2014
IPO DateNov 20, 2020
IndustryBiotechnology
SectorHealthcare
Employees570
CEOBernd Brust

Contact Details

Address:
10770 Wateridge Circle, Suite 200
San Diego, California 92121
United States
Phone858 546 0004
Websitemaravai.com

Stock Details

Ticker SymbolMRVI
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$27.00
CIK Code0001823239
CUSIP Number56600D107
ISIN NumberUS56600D1072
SIC Code2834

Key Executives

NamePosition
Bernd BrustChief Executive Officer and Director
Robert Andrew Eckert M.B.A., MBAChairman of the Board
Dr. Peter Michael Leddy Ph.D.Executive Vice President and Chief Administrative Officer
Rebecca BuzzeoExecutive Vice President and Chief Commercial Officer
Rajesh J. AsarpotaExecutive Vice President and Chief Financial Officer
Debra HartSenior Director of Investor Relations
Kurt Oreshack J.D.Executive Vice President, General Counsel and Secretary
Christine DolanExecutive Vice President and GM of Cygnus Technologies
Dr. Kate E. Broderick Ph.D.Executive Vice President and Chief Innovation Officer
Christopher C. BenoitExecutive Vice President and Advisor

Latest SEC Filings

DateTypeTitle
Jul 29, 2025SCHEDULE 13G/AFiling
Jul 18, 20258-KCurrent Report
Jun 25, 20258-KCurrent Report
Jun 9, 20258-KCurrent Report
May 29, 2025SCHEDULE 13GFiling
May 28, 20258-KCurrent Report
May 12, 2025S-8Securities to be offered to employees in employee benefit plans
May 12, 202510-QQuarterly Report
May 12, 20258-KCurrent Report
Apr 18, 2025ARSFiling